View on Pubmed.gov 26725058 | View on doi.org 10.1007/s10620-...
Function of Autophagy in Nonalcoholic Fatty Liver Disease.
- Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, 615 Michael Street, Suite 201, Atlanta, GA, 30322, USA. mark.j.czaja@emory.edu.
Abstract
Autophagy is a lysosomal degradative pathway that functions to promote cell survival by supplying energy in times of stress or by removing damaged organelles and proteins after injury. The involvement of autophagy in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) was first suggested by the finding that this pathway mediates the breakdown of intracellular lipids in hepatocytes and therefore may regulate the development of hepatic steatosis. Subsequent studies have demonstrated additional critical functions for autophagy in hepatocytes and other hepatic cell types such as macrophages and stellate cells that regulate insulin sensitivity, hepatocellular injury, innate immunity, fibrosis, and carcinogenesis. These findings suggest a number of possible mechanistic roles for autophagy in the development of NAFLD and progression to NASH and its complications. The functions of autophagy in the liver, together with findings of decreased hepatic autophagy in association with conditions that predispose to NAFLD such as obesity and aging, suggest that autophagy may be a novel therapeutic target in this disease.
References
Semin Cell Dev Biol. 2010 Sep;21(7):719-26
Hepatology. 2013 Nov;58(5):1644-54
Nat Med. 2000 Sep;6(9):998-1003
Cell Death Differ. 2013 Jul;20(7):878-87
Cited by 176 citations (total)
Journal Article Research Support, N.I.H., Extramural
MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
Electronic publication date March 30, 2020
Xiaoqin Wu [...] Laura E Nagy et al.
BACKGROUND & AIMS
Autophagy maintains cellular homeostasis and plays a critical role in the development of non-alcoholic fatty liver and steatohepatitis....
Journal Article
Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes.
Electronic publication date June 14, 2019
Juan He [...] Side Liu et al.
Irbesartan has shown significant therapeutic effects in hypertensive patients with non-alcoholic fatty liver disease (NAFLD). To determine the underlying mechanisms...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •